文献速递治疗药物监测与药物基因组学药物不良反应与药物警戒

未接受万古霉素患者出现假性升高血药浓度一例

Falsely Elevated Vancomycin Concentrations in a Patient Not Receiving Vancomycin.
PubMed 文献 · Pharmacotherapy · 2019-06-06

本文报告一例疑似脓毒性膝关节患者,在未接受万古霉素治疗的情况下,Roche Modular P分析仪报告万古霉素浓度为36.1 mg/L,且48小时及8个月后仍高;液相色谱-串联质谱法未检出万古霉素。经聚乙二醇沉淀和热灭活可去除干扰,四种替代免疫法测得浓度从检测不到至108 mg/L不等。

要点

  • 免疫法监测万古霉素可能因内源性蛋白干扰出现假性升高。
  • 当万古霉素浓度与临床不符时,应考虑检测干扰并联系实验室。
  • 液相色谱-串联质谱法可用于确认免疫法假性升高。

核心结论

  • 免疫法测定万古霉素可因内源性蛋白干扰出现假性升高,需警惕检测干扰。

研究设计与样本

  • 单例病例报告,描述一例未接受万古霉素患者出现假性升高血清万古霉素浓度。

主要发现

  • Roche Modular P分析仪报告万古霉素浓度为36.1 mg/L,且在48小时及8个月后仍高。
  • 液相色谱-串联质谱法未检出患者样本中的万古霉素。
  • 聚乙二醇沉淀和热灭活可去除 responsible 干扰。
  • 四种替代免疫法测得万古霉素浓度从检测不到至108 mg/L不等。
  • 两种干扰最大的免疫法均采用葡萄糖-6-磷酸脱氢酶检测方法。

临床怎么用

  • 当万古霉素免疫法检测浓度与临床预期不符时,应考虑检测干扰并联系实验室专业人员。

局限性

  • 本文为单例病例报告,结论外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Therapeutic drug monitoring (TDM) of vancomycin is commonly performed using immunoassays. This case describes falsely elevated vancomycin serum concentrations, possibly secondary to endogenous protein interference. Vancomycin was prescribed for a patient with a suspected septic knee. A blood sample for TDM was inadvertently collected before the first dose. The reported concentration was 36.1 mg/L using the Roche Modular P analyzer and remained high over the next 48 hours and 8 months later in the absence of vancomycin therapy. Vancomycin was undetectable in the patient sample by liquid chromatography-tandem mass spectrometry. The sample was subsequently investigated for endogenous protein interference. The responsible interference was removed by polyethylene glycol precipitation and heat inactivation. Four alternative immunoassays with varying test principles measured vancomycin concentrations ranging from undetectable to 108 mg/L. A glucose-6-phosphate dehydrogenase detection method was common to the two immunoassays exhibiting the greatest interference. To our knowledge, this is the first report of falsely elevated vancomycin concentrations on the Roche Modular P analyzer. Immunoassays are generally robust in facilitating TDM but are susceptible to cross-reactivity. Assay interference should be considered and laboratory professionals contacted when vancomycin levels do not correlate with clinical expectations.

来源:Pharmacotherapy,查看原文。版权归原作者所有。

引用

  1. Tsoi V, Bhayana V, Bombassaro AM, et al. Falsely Elevated Vancomycin Concentrations in a Patient Not Receiving Vancomycin. Pharmacotherapy. 2019. PMID: 31077424. doi:10.1002/phar.2279

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。